BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 28681347)

  • 1. New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.
    D'Amico G; Morabito A; D'Amico M; Pasta L; Malizia G; Rebora P; Valsecchi MG
    Hepatol Int; 2018 Feb; 12(Suppl 1):34-43. PubMed ID: 28681347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
    Bosch J; Iwakiri Y
    Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis.
    Zipprich A; Garcia-Tsao G; Rogowski S; Fleig WE; Seufferlein T; Dollinger MM
    Liver Int; 2012 Oct; 32(9):1407-14. PubMed ID: 22679906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Decompensation and Outcomes in Patients With Compensated Cirrhosis and a Hepatic Venous Pressure Gradient ≥20 mm Hg.
    Jindal A; Bhardwaj A; Kumar G; Sarin SK
    Am J Gastroenterol; 2020 Oct; 115(10):1624-1633. PubMed ID: 32453061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic venous pressure gradient and outcomes in cirrhosis.
    Ripoll C
    J Clin Gastroenterol; 2007; 41 Suppl 3():S330-5. PubMed ID: 17975485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic markers in patients with cirrhosis and portal hypertension who have not bled.
    Poca M; Puente A; Graupera I; Villanueva C
    Dis Markers; 2011; 31(3):147-54. PubMed ID: 22045400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Evaluation and Prognosis.
    Hernández-Gea V; Berzigotti A
    Dig Dis; 2015; 33(4):515-23. PubMed ID: 26159268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis].
    Zhang JY; Kuai JH; Jia JD; Wang BE; Qin CY
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):263-5. PubMed ID: 19403023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation and complications associated with cirrhosis of the liver.
    Poordad FF
    Curr Med Res Opin; 2015 May; 31(5):925-37. PubMed ID: 25697811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of acute variceal bleeding.
    Abraldes JG; Bosch J
    J Clin Gastroenterol; 2007; 41 Suppl 3():S312-7. PubMed ID: 17975482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of cirrhosis: the clinical use of HVPG measurements.
    Albilllos A; Garcia-Tsao G
    Dis Markers; 2011; 31(3):121-8. PubMed ID: 22045397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis.
    Villanueva C; Torres F; Sarin SK; Shah HA; Tripathi D; Brujats A; Rodrigues SG; Bhardwaj A; Azam Z; Hayes PC; Jindal A; Abid S; Alvarado E; Bosch J;
    J Hepatol; 2022 Oct; 77(4):1014-1025. PubMed ID: 35661713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing the development of varices in cirrhosis.
    Garcia-Tsao G
    J Clin Gastroenterol; 2007; 41 Suppl 3():S300-4. PubMed ID: 17975480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients.
    D'Amico G; Pasta L; Morabito A; D'Amico M; Caltagirone M; Malizia G; Tinè F; Giannuoli G; Traina M; Vizzini G; Politi F; Luca A; Virdone R; Licata A; Pagliaro L
    Aliment Pharmacol Ther; 2014 May; 39(10):1180-93. PubMed ID: 24654740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a standardised protocol for hepatic venous pressure gradient measurement improves quality of readings and facilitates reduction of variceal bleeding in cirrhotics.
    Tey TT; Gogna A; Irani FG; Too CW; Lo HG; Tan BS; Tay KH; Lui HF; Chang PE
    Singapore Med J; 2016 Mar; 57(3):132-7. PubMed ID: 26996384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Liver Injury and Decompensated Cirrhosis.
    Crismale JF; Friedman SL
    Med Clin North Am; 2020 Jul; 104(4):647-662. PubMed ID: 32505258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic markers in patients who have recovered from an acute variceal bleeding: role of HVPG measurement.
    Bañares R; Catalina MV; Ripoll C; Rincón D
    Dis Markers; 2011; 31(3):165-9. PubMed ID: 22045402
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.